InMode Ltd. (NASDAQ:INMD) Given Consensus Rating of “Hold” by Analysts

InMode Ltd. (NASDAQ:INMD) has earned a consensus recommendation of “Hold” from the six brokerages that are presently covering the stock, Marketbeat reports. Four analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $22.60.

Several equities analysts have issued reports on the company. Needham & Company LLC reiterated a “hold” rating on shares of InMode in a research note on Thursday, October 31st. BTIG Research began coverage on shares of InMode in a report on Thursday, October 17th. They issued a “buy” rating and a $25.00 price target on the stock. Finally, Barclays reduced their price objective on shares of InMode from $29.00 to $27.00 and set an “overweight” rating for the company in a research note on Monday, October 14th.

Institutional Trading of InMode

Several large investors have recently bought and sold shares of INMD. Asset Dedication LLC purchased a new stake in shares of InMode during the second quarter valued at $33,000. nVerses Capital LLC purchased a new stake in InMode during the 2nd quarter valued at about $42,000. Nisa Investment Advisors LLC increased its holdings in shares of InMode by 314.7% in the third quarter. Nisa Investment Advisors LLC now owns 3,550 shares of the healthcare company’s stock valued at $60,000 after purchasing an additional 2,694 shares during the period. Quarry LP increased its holdings in shares of InMode by 154.3% in the third quarter. Quarry LP now owns 3,781 shares of the healthcare company’s stock valued at $64,000 after purchasing an additional 2,294 shares during the period. Finally, National Bank of Canada FI raised its stake in shares of InMode by 40.7% in the second quarter. National Bank of Canada FI now owns 9,406 shares of the healthcare company’s stock worth $168,000 after purchasing an additional 2,720 shares during the last quarter. Hedge funds and other institutional investors own 68.04% of the company’s stock.

InMode Trading Up 1.6 %

Shares of NASDAQ:INMD opened at $16.96 on Friday. The company has a market capitalization of $1.42 billion, a PE ratio of 9.17 and a beta of 2.07. InMode has a 12-month low of $14.87 and a 12-month high of $26.80. The business’s fifty day simple moving average is $18.18 and its 200-day simple moving average is $17.35.

InMode Company Profile

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.